Antimicrobial Drugs Notes
The History of Chemotherapy
Paul Ehrlich's Contribution: Credited for the birth of chemotherapy in early 20th century Germany.
Speculated about a 'magic bullet' to selectively destroy pathogens without harming the host.
Introduced the concept of selective toxicity.
Coined the term chemotherapy.
Key Concepts in Chemotherapy
Selective Toxicity: Ability to selectively find and destroy pathogens without damaging the host.
Chemotherapy: The use of chemicals to treat diseases.
Discovery of Antibiotics
Alexander Fleming (1928):
Discovered that the bacterium Staphylococcus aureus was inhibited by a mold (Penicillium notatum).
This led to the isolation of penicillin, the first antibiotic.
Introduced the term antibiosis, referring to substances produced by microorganisms to inhibit others.
Distinguishes between synthetic antimicrobial drugs and semisynthetic drugs (chemically modified in labs).
Antibiotic Development and Resistance
Antibiotics are easy to discover, but few hold medical or commercial value due to the rising problem of antibiotic resistance.
Sources of Antibiotics
Gram-Positive Rods:
Bacillus subtilis - Bacitracin
Paenibacillus polymyxa - Polymyxin
Over half produced by the genus Streptomyces which includes:
Streptomyces aureofaciens - Chloramphenicol
Fungi:
Penicillium chrysogenum - Penicillin.
Spectrum of Activity
Narrow Spectrum: Targets a specific group of microbes (either Gram-positive or Gram-negative).
Broad-Spectrum: Targets a wide variety of microbes (both Gram-positive and Gram-negative).
Classification of Antimicrobials
Bacteriostatic (inhibit growth) vs. Bactericidal (kill bacteria).
Examples of Bacteriostatic:
Chloramphenicol, Erythromycin, Clindamycin.
Examples of Bactericidal:
Aminoglycosides, Beta-lactams, Vancomycin.
Mechanisms of Action for Antibiotics
Inhibition of Cell Wall Synthesis:
Penicillins, Cephalosporins, Bacitracin, Vancomycin.
Inhibition of Protein Synthesis:
Chloramphenicol, Erythromycin, Tetracyclines, Streptomycin.
Inhibition of Nucleic Acid Replication and Transcription:
Quinolones, Rifampin.
Injury to Plasma Membrane:
Polymyxin B.
Inhibition of Essential Metabolite Synthesis:
Sulfanilamide, Trimethoprim.
Cell Wall Synthesis Inhibitors
Penicillins: Group of over 50 antibiotics with a common β-lactam ring.
Natural: Extracted from Penicillium; examples include Penicillin G (injection) and Penicillin V (oral).
Disadvantages: Narrow activity spectrum; susceptible to penicillinases (β-lactamases).
Resistance to Penicillins
Penicillinases: Enzymes that cleave the β-lactam ring, leading to resistance, particularly in Staphylococcus aureus.
Semisynthetic Penicillins
Developed to overcome natural penicillin limitations.
Oxacillin: Narrow spectrum, resistant to penicillinase.
Aminopenicillins: Extended spectrum, effective against Gram-negatives.
Penicillins + β-lactamase inhibitors: Example - Amoxicillin + Clavulanic Acid = Augmentin.
Carbapenems and Cephalosporins
Carbapenems: Broad spectrum, often reserved for severe infections.
Cephalosporins: Grouped by development generation, effective against Gram-positive and some Gram-negative bacteria.
Protein Synthesis Inhibitors
Chloramphenicol: Binds to the 50S ribosome, inhibiting peptide bond formation; can cause bone marrow suppression.
Aminoglycosides: Change the shape of the 30S subunit, can cause side effects like auditory damage.
Tetracyclines: Broad-spectrum antibiotics, risk of suppressing beneficial intestinal microbiota.
Nucleic Acid Synthesis Inhibitors
Rifampin: Important in treating tuberculosis; penetrates tissues effectively.
Quinolones: Inhibit DNA gyrase, examples include Ciprofloxacin.
Antifungal and Antiviral Drugs
Antifungal Treatments: Focused on targeting ergosterol in fungal plasma membranes.
Examples include Nystatin and Amphotericin B.
Antiviral Drugs: Focus on inhibiting viral entry, nucleic acid synthesis, and maturation processes.
Drug Testing and Susceptibility
Kirby-Bauer Test: Measures zones of inhibition to evaluate antibiotic effectiveness.
Minimum Inhibitory Concentration (MIC): Smallest effective dose correlating with the size of inhibition zones.
Therapeutic Index
Definition: Ratio of the toxic dose to the effective dose; a larger therapeutic index indicates a safer drug.
Example Calculation:
Drug X: TD50 = 18ug/ul, ED50 = 10ug/ul -> TI = 1.8
Drug Y: TD50 = 23ug/ul, ED50 = 21ug/ul -> TI = 1.095
Drug Z: TD50 = 15ug/ul, ED50 = 2ug/ul -> TI = 7.5
Community Acquired Pneumonia (CAP)
Empiric Treatment examples based on patient type and comorbidities.
Treatment includes macrolides or respiratory fluoroquinolones based on resistance patterns.